RBC Europe’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-480
Closed -$7.07K 1047
2021
Q3
$7.07K Sell
480
-3,968
-89% -$67K ﹤0.01% 994
2021
Q2
$81K Hold
4,448
﹤0.01% 476
2021
Q1
$77.2K Hold
4,448
﹤0.01% 456
2020
Q4
$77.3K Hold
4,448
﹤0.01% 429
2020
Q3
$61.3K Buy
4,448
+3,968
+827% +$58.3K ﹤0.01% 425
2020
Q2
$6.93K Hold
480
﹤0.01% 829
2020
Q1
$5.24K Hold
480
﹤0.01% 826
2019
Q4
$10.2K Hold
480
﹤0.01% 797
2019
Q3
$11K Buy
+480
New +$10.2K ﹤0.01% 769
2017
Q4
Sell
-230
Closed -$5.05K 1156
2017
Q3
$5.05K Buy
+230
New +$5.2K ﹤0.01% 949

Other funds holding SBRA

RBC Europe's SBRA Position: Q4 2021 in Review

RBC Europe sold out of Sabra Healthcare REIT (SBRA) in Q4 2021, closing a stake of 480 shares — an estimated $7.07K sold.

RBC Europe first reported a position in SBRA in Q3 2017 and held it in 10 quarters. The position peaked at $81K in Q2 2021. 337 funds tracked by Wall St. Rank hold SBRA as of Q4 2021.

  • RBC Europe reported no remaining Sabra Healthcare REIT position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 480 Sabra Healthcare REIT shares in Q4 2021, an estimated $7.07K.
  • RBC Europe first reported a position in Sabra Healthcare REIT in Q3 2017 and held it in 10 quarters.
  • RBC Europe's Sabra Healthcare REIT position peaked at $81K in Q2 2021.
  • 337 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.